Painkiller registration revoked in Kazakhstan

Kazakhstan has canceled the marketing authorizations for Tramadol Lannacher tablets in 100 mg and 150 mg strengths. The decision was made by the Ministry of Health's Committee for Medical and Pharmaceutical Control.

According to the department, the revocation was initiated by the registration holder, Bausch Health LLC (Russia), as part of a corporate business decision. Importantly, the move is not linked to any issues concerning the quality, efficacy, or safety of the medication. Tramadol Lannacher is a prescription opioid analgesic used to manage moderate to severe pain.

Despite the withdrawal of these specific Tramadol Lannacher products, other tramadol-based medications remain approved for patient use in Kazakhstan. As of August 13, 2026, the country's state register of medicines lists seven registered tramadol products. These are available in both tablet and injectable forms and are manufactured by Protech Biopharma Pvt. Ltd. (India), G.L. Pharma GmbH (Austria), and Chimpharm JSC (Kazakhstan).